What we know

The Prima implant is a new device designed to restore some vision for patients with age-related macular degeneration (AMD), but current evidence for its effectiveness is limited and not yet independently verified by multiple high-reliability sources. The Prima implant can restore sight for patients with macular degeneration. The Prima system was approved in Europe in 2023.

Why it matters

Age-related macular degeneration (AMD) is a leading cause of vision loss, affecting millions worldwide. Traditional treatments can slow progression but have not restored lost vision. The Prima system is a retinal implant that aims to partially restore sight by converting images from special glasses into electrical signals sent to the retina.

What is still unknown

Independent tests of accuracy, supported languages, and a broader release date are not in the reporting.